Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047463 · ClinicalTrials.gov registry record · Phase 2
Effects of Treating Obstructive Sleep Apnea in Epilepsy
A Phase 2 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT00047463 is a Phase 2 study that has completed, run by Vanderbilt University. The registered enrollment target is 68 participants.
The verdict
NCT00047463, a Phase 2 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this trial is to work out design issues prior to conducting a definitive phase 3 trial to determine whether treating sleep-related breathing disorders in people with epilepsy results in improvement in seizure control or an improvement in alertness during the day.
Interventions
- DEVICE continuous positive airway pressure (CPAP)
- DEVICE Placebo-CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00047463
The ClinicalTrials.gov registry entry for NCT00047463 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which continuous positive airway pressure (CPAP) is the first listed.
NCT00047463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00047463 about?
NCT00047463 is a clinical study titled "Effects of Treating Obstructive Sleep Apnea in Epilepsy". The purpose of this trial is to work out design issues prior to conducting a definitive phase 3 trial to determine whether treating sleep-related breathing disorders in people with epilepsy results in improvement in seizure control or an improvement in alertness during the day.
What is the current status of trial NCT00047463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2002-09. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00047463?
The interventions under investigation include: continuous positive airway pressure (CPAP) (DEVICE), Placebo-CPAP (DEVICE).
Who is sponsoring clinical trial NCT00047463?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.